Psychological functioning and quality of life in patients with mastocytosis
- 1 April 2020
- journal article
- research article
- Published by Elsevier in Annals of Allergy, Asthma & Immunology
- Vol. 124 (4) , 373-378.e2
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Mast Cell Mediators of Significance in Clinical Practice in MastocytosisImmunology and Allergy Clinics of North America, 2018
- Low frequency of acetyl salicylic acid hypersensitivity in mastocytosis: The results of a double‐blind, placebo‐controlled challenge studyAllergy, 2018
- Mastocytosis: 2016 updated WHO classification and novel emerging treatment conceptsBlood, 2017
- Mast cells' involvement in inflammation pathways linked to depression: evidence in mastocytosisMolecular Psychiatry, 2016
- Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on MastocytosisAllergy, 2014
- The Mastocytosis Society Survey on Mast Cell Disorders: Patient Experiences and PerceptionsThe Journal of Allergy and Clinical Immunology: In Practice, 2014
- Evidence for Cognitive Impairment in Mastocytosis: Prevalence, Features and Correlations to DepressionPLOS ONE, 2012
- Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factorsBlood, 2009
- Case-Control Cohort Study of Patients' Perceptions of Disability in MastocytosisPLOS ONE, 2008
- Translation, Validation, and Norming of the Dutch Language Version of the SF-36 Health Survey in Community and Chronic Disease PopulationsJournal of Clinical Epidemiology, 1998